1 / 6

Exploring New paradigms for Health R&D

Exploring New paradigms for Health R&D. Dr Shaidah Asmall October 2007. Product Development. To global physical, mental and social well-being. Absence of Solutions. Pharma innovate drugs for developed countries Rate of Innovation decreasing Correa

bien
Download Presentation

Exploring New paradigms for Health R&D

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Exploring New paradigms for Health R&D Dr Shaidah Asmall October 2007

  2. Product Development To global physical, mental and social well-being Absence of Solutions

  3. Pharma innovate drugs for developed countries Rate of Innovation decreasing Correa Appropriate profit motive will lead to innovation IAVI one of first vaccine development initiatives At present more than 80 in development Big pharma actively involved in vaccine development However limited success Lack of ability to pay 20 years Chinese economy larger than USA although % of poor will be large – today 700m below $2 day Indian economy also expanding Cover about a third of world population Validity of Assumptions

  4. Biotech and Nanotech “revolution” Rate of new developments in health are increasing However, majority at the conceptual stage Known targets but looking for new entities/delivery vehicles Shorter Cycle “mind to market” IT cycle is about 15 months Biotech cycle is about 30 months Future Scenarios

  5. Prizes for ideas Funding for development Patent pool; CAMC for commercialisation Possible interventionsin value chain

  6. Acknowledgements

More Related